WHO: Coronavirus cases declining everywhere except Europe

LONDON – The World Health Organization reported Wednesday that coronavirus deaths rose by 10% in Europe in the past week, making it the only world region where both COVID-19 cases and deaths are steadily increasing. It was the sixth consecutive week that the virus has risen across the continent.

In its weekly report on the pandemic, the U.N. health agency said there were about 3.1 million new cases globally, about a 1% increase from the previous week. Nearly two-thirds of the coronavirus infections – 1.9 million – were in Europe, where cases rose by 7%.

The countries with the highest numbers of new cases worldwide were the United States, Russia, Britain, Turkey and Germany. The number of weekly COVID-19 deaths fell by about 4% worldwide and declined in every region except Europe.

Out of the 61 countries WHO includes in its European region, which includes Russia and stretches to Central Asia, 42% reported a jump in cases of at least 10% in the last week.

In the Americas, WHO said that new weekly cases fell by 5% and deaths declined by 14%, with the highest numbers reported from the United States.

On Tuesday, pharmaceutical company Pfizer asked the U.S. Food and Drug Administration to authorize booster shots of coronavirus vaccines for all adults. WHO has pleaded with countries not to administer more boosters until at least the end of the year; about 60 countries are actively rolling them out.

In Southeast Asia and Africa, COVID-19 deaths declined by about a third, despite the lack of vaccines in those regions.

WHO’s Europe director, Dr. Hans Kluge, said last week that Europe was once again “back at the epicenter of the pandemic.” He warned that if more actions weren’t taken to stop COVID-19, the region could see another 500,000 deaths by February.

  • Related Posts

    Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

    Andelyn bio sciences Inc, a leading patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has partnered with Queen’s University to develop and manufacture AAV9-GM2, a gene therapy…

    Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

    Cellution Biologics Inc, a biologics company focused on developing, manufacturing and commercializing advanced human tissue-based products, announced the completion of its acquisition of the SimpliDerm hydrated human acellular dermal matrix…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

    Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

    Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

    Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

    ACB Gujarat arrested two FDA Officials red-handed in Bharuch accepting a bribe of ₹40,000

    ACB Gujarat arrested two FDA Officials red-handed in Bharuch accepting a bribe of ₹40,000

    US appeals court sides with Sun Pharma in Lipitor antitrust case

    US appeals court sides with Sun Pharma in Lipitor antitrust case

    Counterfeit Cosmetics Are No Longer a Fringe Problem: 4 in 10 Consumers Report Fake Products, Regulatory Silence Raises Serious Questions

    Counterfeit Cosmetics Are No Longer a Fringe Problem: 4 in 10 Consumers Report Fake Products, Regulatory Silence Raises Serious Questions

    Three arrested for illegal sale of mephentermine sulphate injections in Hyderabad

    Three arrested for illegal sale of mephentermine sulphate injections in Hyderabad